4Abrams P, Cardozo L,Fall M,et al.The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society[J].Am J Obstet Gynecol,2002,187(1): 116-126.
6Dominick KL,Dudley TK,Coffman CJ,et al.Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis[J].Arthritis Rheum,20055(3):666-672.
8Sloan KL,Sales AE,Liu CF, et al.Construction and characteristics of the RxRisk-V:a VA-adapted pharmacy-based case-mix instrument[J]. Med Care,2003,4(l)761-774.
9Fiorucci S,Distrutti E.Role of PAR-2 in pain and inflammation[J]. Trends Pharmacol Sci,2003, 23:153-155.
10Fiorucci S,Mencarelli A, Palazzetti B,et aI.Cirino G. Proteinaseactivated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis[J].Proc Natl Acad Sci USA,2001,9(8):I3 936-13 941.
2Vitali C,Bombardieri S,Jonsson R,et al.Classification criteria for Sjgren’s syndrome:a revised version of the European criteria proposed by the American-European Consensus Group[J].Ann Rheum Dis,2002,61:554-558.
3Gillenwater JY,Wein AJ.Summary of the National Institute of Arthritis,Diabetes,Digestive and Kidney Diseases Workshop on Interstitial Cystitis[J].J Urol,1988,140:203-206.
4Homma Y,Ueda T,Tomoe H,et al.Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome.Int J Urol,2009,16:597-615.
5Curhan GC,Speizer FE,Hunter DJ,et al.Epidemiology of interstitial cystitis:a population based study[J].J Urol,1999,161:549-552.
6Van de Merwe JP.Interstitial cystitis and systemic autoimmune disease[J].Nat Clin Pract Urol,2007,9:484-491.
7Van de Merwe JP,Yamada T,Sakamoto Y.Systemic aspects of interstitial cystitis,immunology and linkage with autoimmune disorders.Int J Urol,2003,10Suppl:S35-38.
